Estrogen-related receptor γ controls hepatic CB1 receptor-mediated CYP2E1 expression and oxidative liver injury by alcohol

Gut

Volumn 62, Issue 7, 2013, Pages 1044-1054

  Kim, Don Kyu ^a,b   Kim, Yong Hoon ^c   Jang, Hyun Hee ^b   Park, Jinyoung ^d   Kim, Jung Ran ^e   Koh, Minseob ^f   Jeong, Won Il ^g   Koo, Seung Hoi ^d   Park, Tae Sik ^e   Yun, Chul Ho ^b   Park, Seung Bum ^f   Chiang, John Y L ^h   Lee, Chul Ho ^c   Choi, Hueng Sik ^a,b,i  

^a National Creative Research Initiatives Center for Nuclear Receptor Signals   (South Korea)

^b Chonnam National University   (South Korea)

^c Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^d Sungkyunkwan University School of Medicine   (South Korea)

^e Gachon University College of Medicine   (South Korea)

^f Seoul National University   (South Korea)

^g Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^h Northeastern Ohio Medical University   (United States)

ⁱ Chonnam National University Medical School   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; CANNABINOID 1 RECEPTOR; CLOMETHIAZOLE; CYTOCHROME P450 2E1; ESTROGEN RELATED RECEPTOR GAMMA; GSK 5182; REACTIVE OXYGEN METABOLITE; STEROID RECEPTOR; UNCLASSIFIED DRUG;

ALCOHOL LIVER CIRRHOSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANNABINOID 1 RECEPTOR GENE; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME REGULATION; ESTROGEN RELATED RECEPTOR GAMMA GENE; GENE; GENE EXPRESSION; MALE; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

ALCOHOL-INDUCED INJURY; ALCOHOLIC LIVER DISEASE; GENE REGULATION; LIVER; LIVER METABOLISM;

ANIMALS; CYTOCHROME P-450 CYP2E1; ENZYME INHIBITORS; ETHANOL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, ENZYMOLOGIC; LIVER; LIVER DISEASES, ALCOHOLIC; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OXIDATION-REDUCTION; OXIDATIVE STRESS; RECEPTOR, CANNABINOID, CB1; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION; TAMOXIFEN; TRANSCRIPTION, GENETIC;

EID: 84878759800     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2012-303347     Document Type: Article

References (44)

1. Gao B, Bataller R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 2011;141:1572-85.
2. Dey A, Cederbaum AI. Alcohol and oxidative liver injury. Hepatology 2006;43:S63-74.
3. Cederbaum AI, Lu Y, Wu D. Role of oxidative stress in alcohol-induced liver injury. Arch Toxicol 2009;83:519-48.
4. Arteel GE. Oxidants and antioxidants in alcohol-induced liver disease. Gastroenterology 2003;124:778-90. (Pubitemid 36268494)
5. Lieber CS. Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol 2004;34:9-19. (Pubitemid 40163989)
6. Gonzalez FJ. Role of cytochromes P450 in chemical toxicity and oxidative stress: studies with CYP2E1. Mutat Res 2005;569:101-10. (Pubitemid 39643260)
7. Sugiura T, Kobayashi Y, Oka S, et al. Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance. Prostaglandins Leukot Essent Fatty Acids 2002;66:173-92. (Pubitemid 34743593)
8. Bisogno T, Howell F, Williams G, et al. Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J Cell Biol 2003; 163:463-8. (Pubitemid 37429860)
9. Gao Y, Vasilyev DV, Goncalves MB, et al. Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice. J Neurosci 2010;30:2017-24.
10. Jeong WI, Osei-Hyiaman D, Park O, et al. Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver. Cell Metab 2008;7:227-35. (Pubitemid 351285525)
11. Tam J, Liu J, Mukhopadhyay B, et al. Endocannabinoids in liver disease. Hepatology 2011;53:346-55.
12. Giguere V. Transcriptional control of energy homeostasis by the estrogen-related receptors. Endocr Rev 2008;29:677-96.
13. Chao EY, Collins JL, Gaillard S, et al. Structure-guided synthesis of tamoxifen analogs with improved selectivity for the orphan ERRgamma. Bioorg Med Chem Lett 2006;16:821-4. (Pubitemid 43059830)
14. Kim DK, Ryu D, Koh M, et al. Orphan Nuclear Receptor Estrogen-Related Receptor gamma (ERRgamma) Is Key Regulator of Hepatic Gluconeogenesis. J Biol Chem 2012;287:21628-39.
15. Hong H, Yang L, Stallcup MR. Hormone-independent transcriptional activation and coactivator binding by novel orphan nuclear receptor ERR3. J Biol Chem 1999;274:22618-26.
16. Lui K, Huang Y, Choi HL, et al. Molecular cloning and functional study of rat estrogen receptor-related receptor gamma in rat prostatic cells. Prostate 2006;66:1600-19. (Pubitemid 44646352)
17. Dufour CR, Wilson BJ, Huss JM, et al. Genome-wide orchestration of cardiac functions by the orphan nuclear receptors ERRalpha and gamma. Cell Metab 2007;5:345-56. (Pubitemid 46667756)
18. Alaynick WA, Kondo RP, Xie W, et al. ERRgamma directs and maintains the transition to oxidative metabolism in the postnatal heart. Cell Metab 2007;6:13-24. (Pubitemid 46995781)
19. Kim DK, Kim JR, Koh M, et al. Estrogen-related Receptor gamma (ERRgamma) Is a Novel Transcriptional Regulator of Phosphatidic Acid Phosphatase, LIPIN1, and Inhibits Hepatic Insulin Signaling. J Biol Chem 2011;286:38035-42.
20. Jarai Z, Wagner JA, Varga K, et al. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Proc Natl Acad Sci USA 1999;96:14136-41.
21. Wang L, Liu J, Harvey-White J, et al. Endocannabinoid signaling via cannabinoid receptor 1 is involved in ethanol preference and its age-dependent decline in mice. Proc Natl Acad Sci USA 2003;100:1393-8. (Pubitemid 36184012)
22. Lu Y, Zhuge J, Wang X, et al. Cytochrome P450 2E1 contributes to ethanol-induced fatty liver in mice. Hepatology 2008;47:1483-94. (Pubitemid 351702732)
23. Ahn T, Yun CH, Oh DB. Tissue-specific effect of ascorbic acid supplementation on the expression of cytochrome P450 2E1 and oxidative stress in streptozotocin-induced diabetic rats. Toxicol Lett 2006;166:27-36. (Pubitemid 44279301)
24. Peter R, Bocker R, Beaune PH, et al. Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450IIE1. Chem Res Toxicol 1990;3:566-73.
25. Kim DH, Kim KH, Isin EM, et al. Heterologous expression and characterization of wild-type human cytochrome P450 1A2 without conventional N-terminal modification in Escherichia coli. Protein Expr Purif 2008;57:188-200. (Pubitemid 350296980)
26. Rueda D, Galve-Roperh I, Haro A, et al. The CB(1) cannabinoid receptor is coupled to the activation of c-Jun N-terminal kinase. Mol Pharmacol 2000;58:814-20.
27. Maccarrone M, Finazzi-Agro A. The endocannabinoid system, anandamide and the regulation of mammalian cell apoptosis. Cell Death Differ 2003;10:946-55. (Pubitemid 37069472)
28. Hu Y, Mishin V, Johansson I, et al. Chlormethiazole as an efficient inhibitor of cytochrome P450 2E1 expression in rat liver. J Pharmacol Exp Ther 1994;269:1286-91. (Pubitemid 24204216)
29. Fang C, Lindros KO, Badger TM, et al. Zonated expression of cytokines in rat liver: effect of chronic ethanol and the cytochrome P450 2E1 inhibitor, chlormethiazole. Hepatology 1998;27:1304-10. (Pubitemid 28227857)
30. Lu Y, Cederbaum AI. CYP2E1 and oxidative liver injury by alcohol. Free Radic Biol Med 2008;44:723-38.
31. Lieber CS. CYP2E1: from ASH to NASH. Hepatol Res 2004;28:1-11. (Pubitemid 38145781)
32. Hanus LO. Pharmacological and therapeutic secrets of plant and brain (endo) cannabinoids. Med Res Rev 2009; 29:213-71.
33. Tanasescu R, Constantinescu CS. Cannabinoids and the immune system: an overview. Immunobiology 2010;215:588-97.
34. Louvet A, Teixeira-Clerc F, Chobert MN, et al. Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating Kupffer cell polarization in mice. Hepatology 2011;54:1217-26.
35. Hezode C, Roudot-Thoraval F, Nguyen S, et al. Daily cannabis smoking as a risk factor for progression of fibrosis in chronic hepatitis C. Hepatology 2005;42:63-71. (Pubitemid 40911312)
36. Siegmund SV, Qian T, de Minicis S, et al. The endocannabinoid 2-arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species. FASEB J 2007;21:2798-806. (Pubitemid 47372747)
37. Batkai S, Mukhopadhyay P, Harvey-White J, et al. Endocannabinoids acting at CB1 receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic rats. Am J Physiol Heart Circ Physiol 2007;293:H1689-95. (Pubitemid 47367216)
38. Kamata H, Honda S, Maeda S, et al. Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 2005;120:649-61. (Pubitemid 40343077)
39. Kim BJ, Ryu SW, Song BJ. JNK- and p38 kinase-mediated phosphorylation of Bax leads to its activation and mitochondrial translocation and to apoptosis of human hepatoma HepG2 cells. J Biol Chem 2006;281:21256-65.
40. Bardag-Gorce F, Yuan QX, Li J, et al. The effect of ethanol-induced cytochrome p4502E1 on the inhibition of proteasome activity by alcohol. Biochem Biophys Res Commun 2000;279:23-9.
41. Bradford BU, Kono H, Isayama F, et al. Cytochrome P450 CYP2E1, but not nicotinamide adenine dinucleotide phosphate oxidase, is required for ethanol-induced oxidative DNA damage in rodent liver. Hepatology 2005;41:336-44. (Pubitemid 40165377)
42. Dostalek M, Brooks JD, Hardy KD, et al. In vivo oxidative damage in rats is associated with barbiturate response but not other cytochrome P450 inducers. Mol Pharmacol 2007;72:1419-24. (Pubitemid 350146079)
43. Dostalek M, Hardy KD, Milne GL, et al. Development of oxidative stress by cytochrome P450 induction in rodents is selective for barbiturates and related to loss of pyridine nucleotide-dependent protective systems. J Biol Chem 2008;283:17147-57.
44. Liu J, Zhou L, Xiong K, et al. Hepatic Cannabinoid receptor-1 mediates diet-induced insulin resistance via inhibition of insulin signaling and clearance in mice. Gastroenterology 2012;142:1218-28 e1.